Le Lézard
Classified in: Health
Subjects: PDT, MAT

Introducing Rare Cannabinoid Company's Latest Innovation: THC + CBN Sleep Gummies for a Restful Night's Sleep


Rare Cannabinoid Company launches THC + CBN Sleep Gummies. These all-natural, vegan, hemp edibles are designed to promote a restful night's sleep. They combine the benefits of Delta-9-THC, CBN oil, and CBD oil into one huckleberry-flavored bedtime edible.

HONOLULU, Nov. 22, 2023 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company, a leading provider of premium hemp-infused products, is thrilled to announce the launch of their newest product, THC + CBN Sleep Gummies. Crafted with care and designed to promote a restful night's sleep, these gummies are set to revolutionize the way people experience CBN products.

Many of our customers say they take our THC Mood Gummies along with our original extra strength CBN Gummies for a dreamy night's sleep, and we're happy to now offer a gummy with the benefits of both THC and CBN in one gummy.

Sleep is essential for overall well-being, and many individuals struggle with sleep disturbances and overactive thoughts that keep them awake at night. THC + CBN Sleep Gummies offer a natural and effective option for those seeking a better night's sleep.

Like the brand's extra strength CBN Gummies for Sleep, each gummy contains 30mg CBN for relaxation, rest, and sleep, as well as 10mg CBD oil for calm, balance, and the entourage effect. What's unique about these gummies is that they also contain 5mg Delta-9-THC to amplify the dreamy relaxing effects.

Key Features of THC + CBN Sleep Gummies:

"We're thrilled to introduce our THC + CBN Sleep Gummies to the market," said a company spokesperson.

"Many of our customers say they take our THC Mood Gummies along with our original extra strength CBN Gummies for a dreamy night's sleep, and we're happy to now offer a gummy with the benefits of both THC and CBN in one gummy."

The THC + CBN Sleep Gummies are now available for purchase on their website as well as at some of the 400 locations that stock their products.

Rare Cannabinoid Company also offers oils and gummies of THCV for energy and appetite control, CBG Gummies for discomfort relief, and CBD Gummies for calm and balance. They are also releasing THC + CBG Relief Gummies and THC + THCV Uplift Gummies to add to their growing THC Gummies line.

For anyone who would like the sleepy benefits of CBN cannabinoid without THC, they also offer a pure CBN oil tincture, CBN CBD blend, as well as the extra strength CBN Gummies with CBD but no Delta-9-THC.

Rare Cannabinoid Company also offers a vast selection of rare cannabinoid oils, Hawaiian Choice CBD, Pet CBD, topical gel, and more.

To learn more about their latest product and commitment to quality, please visit http://www.rarecannabinoidco.com.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, +1 (808)762-1313, [email protected], www.rarecannabinoidco.com

SOURCE Rare Cannabinoid Company


These press releases may also interest you

at 03:40
In the news release, GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025, issued 11-Feb-2025 by GC Biopharma over PR Newswire, we are advised by the company that the 2nd paragraph should read "WORLD Symposium 2025...

at 02:57
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Region Västra Götaland, Sweden's second largest healthcare region, will use Sectra's digital pathology solution. This marks an expansion of a more than...

at 02:54
Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing early cancer detection and precision treatment. Dr. Cristofanilli, an...

at 02:14
Report on how AI is redefining market landscape - The global wearable technology market size is estimated to grow by USD 99.4 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of over 17.3%  during the forecast...

at 02:05
Agendia®, Inc. announced today that the National Institute for Sickness and Invalidity Insurance (INAMI-RIZIV) located in Brussels has expanded the reimbursement indication for MammaPrint® to include its use in the neoadjuvant setting, effective...

at 02:03
PureHealth Holding PJSC ("PureHealth"...



News published on and distributed by: